Sarah Meulebrouck et al.
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas
Diabetologia 2023, vol. 67, issue 2
doi: 10.1007/s00125-023-06035-x
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Sarah Meulebrouck et al.
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas
Diabetologia 2023, vol. 67, issue 2
doi: 10.1007/s00125-023-06035-x